Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|May 11, 2025
Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancerYangyang Jia, Yanru Wang, Guanghao Zhao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2020
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia VirusMark S Ferguson, Louisa S Chard Dunmall, Rathi Gangeswaran, et al.
World Journal of Gastroenterology|September 14, 2020
Promising xenograft animal model recapitulating the features of human pancreatic cancerJin-Xin Miao, Jian-Yao Wang, Hao-Ze Li, et al.
Nature Communications|November 11, 2017
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agentPengju Wang, Xiaozhu Li, Jiwei Wang, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
A new oncolytic Vacciniavirus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgeryJahangir Ahmed, Louisa S Chard, Ming Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2014
A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancerLouisa S Chard, Eleni Maniati, Pengju Wang, et al.
Frontiers in Immunology|September 9, 2020
Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) RegimeZhe Zhang, Shuangshuang Lu, Louisa S Chard Dunmall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2019
A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic CancerShuangshuang Lu, Zhe Zhang, Pan Du, et al.
Pageof 5